News
Investing.com -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock rose 2.4% following the announcement that an abstract on its CRB-701 clinical study has been accepted for presentation at the ...
Holdings announced that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the ...
Abstracts will be made available on the ESMO website on 13 October 2025 at 00.05 CET. The posters will be available on the Posters & Publications section of Immutep’s website after their presentations ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising ...
Abstract: This paper presents a novel light balancing technique to compensate uneven illumination based on adaptive gain control, which is specially designed for text images. A segmentation technique ...
8d
TipRanks on MSNIdeaya Biosciences, Hengrui announce oral presentation at IASLC 2025Ideaya Biosciences (IDYA) and Jiangsu Hengrui Pharmaceuticals Co. announced the publication of an abstract for an oral presentation on IDE849 at ...
Abstract: Content-aware visual-textual presentation layout aims at arranging spatial space on the given canvas for pre-defined elements, including text, logo, and underlay, which is a key to automatic ...
Intradural spinal arachnoid cysts versus spinal arachnoid webs: a retrospective analysis of incidence, imaging findings and clinical presentation at a single institution ...
Clinicians should be aware of this unusual presentation to facilitate timely diagnosis and appropriate management, particularly in at-risk populations. Keywords: Rickets, Vitamin D, Hypocalcemia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results